Abstract
Adeno-associated virus (AAV) vectors have the potential to treat a broad range of genetic diseases, among which, those directed toward blood cells currently hold the greatest promise. There are several reasons why the prospect of transducing blood cells merits such extensive interest. First, the target cells are easily accessible. Populations of cells can be removed from the patient, manipulated ex vivo, and subsequently returned to the patient. They can also be enriched for the cell types of interest, cultured, expanded, and transduced with a number of experimental gene therapy vectors. Perhaps more importantly, pluripotent stem cell populations have been identified which can divide and differentiate to repopulate the blood with the different lineages of cells which make up this complex system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander IE, Russell DW, Miller AD (1994) DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68(12): 8282–8287
Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH (1993) Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362(6422): 722–728
Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD (1994) Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 84(5): 1650–1655
Flotte TR, Afione SA, Zeitlin PL (1994) Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 11(5): 517–521
Gibson RA, Ford D, Jansen S, Savoia A, Havenga C, Milner RD, de-Ravel TJ, Cohn RJ, Ball SE, Roberts I et al (1994) Genetic mapping of the FACC gene and linkage analysis in Fanconi anaemia families. J Med Genet 31(11): 868–871
Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW (1994) Recombinant adeno-associated virus mediated gene transfer into hematopoietic progenitor cells. Blood 84(5): 1492–1500
Grosveld F, van-Assendelft GB, Greaves DR, Kollias G (1987) Position independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51(6): 975–985
Ikuta T, Kan YW (1991) In vivo protein-DNA interactions at the beta-globin gene locus. Proc Natl Acad Sci USA 88(22): 10188–10192
Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfa DW, O’Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet 8: 148–154
Kotin RM, Linden RM, Berns KL (1992) Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 11(13): 5071–5078
Laughlin CA, Cardellichio CB, Coon HC (1986) Latent infection of KB cells with adeno-associated virus type 2. J Virol 60: 515–524
Liu JM, Buchwald M, Walsh CE, Young NS (1994) Fanconi anemia and novel strategies for therapy. Blood 84(12): 3995–4007
McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62(6): 1963–1973
Miller JL, Walsh CE, Ney PA, Samulski RJ, Nienhuis AW (1993) Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adenoassociated virus vectors: the eect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer. Blood 82(6): 1900–1906
Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW (1994) Recombinant adenoassociated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitorderived erythroid cells. Proc Natl Acad Sci USA 91(21): 10183–10187
Ney PA, Sorrentino BP, Lowrey CH, Nienhuis AW (1990a) Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. Nucleic Acids Res 18(20): 6011–6017
Ney PA, Sorrentino BP, McDonagh KT, Nienhuis AW (1990b) Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev 4(6): 993–1006
Papayannopoulou T, Nakamoto B, Kurachi S, Tweeddale M, Messner H (1988) Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood 72(3): 1029–1038
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, Dagati V, Orkin SH, Costantini F (1991) Erythroid dierentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349(6306): 257–260
Philipsen S, Talbot D, Fräser P, Grosveld F (1990) The beta-globin dominant control region: hypersensitive site 2. EMBO J 9(7): 2159–2167
Russell DW, Miller AD, Alexander IE (1994) Adeno-associated virus vectors preferentially transducer cells in S phase. Proc Natl Acad Sci USA 91(19): 8915–8919
Russell DW, Alexander IA, Miller AD (1995) DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 92: 5719–5723
Rutherford TR, Clegg JB, Weatherall DJ (1979) K562 Human leukaemic cells synthesize embryonic haemoglobin in response to haemin. Nature 280: 164–165
Samulski RJ, Chang LS, Shenk T (1989) Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63: 3822–3828
Sorrentino B, Ney P, Bodine D, Nienhius AW (1990) A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid dierentiation. Nucleic Acids Res 18(9): 2721–2731
Strauss EC, Andrews NC, Higgs DR, Orkin SH (1992) In vivo footprinting of the human alpha-globin locus upstream regulatory element by guanine and adenine ligation-mediated polymerase chain reaction. Mol Cell Biol 12(5): 2135–2142
Tuan D, Solomon W, Li Q, London IM (1985) The “beta-like-globin” gene domain in human erythroid cells. Proc Natl Acad Sci USA 82(19): 6384–6388
Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW, Samulski RJ (1992) Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 89(15): 7257–7261
Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM (1994) Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector (see comments). J Clin Invest 94(4): 1440–1448
Weitzman MD, Kyostio SR, Kotin RM, Owens RA (1994) Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 91(13): 5808–5812
Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD (1990) Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev 4(10): 1650–1662
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McCarty, D.M., Samulski, R.J. (1996). Adeno-associated Virus Vectors for Gene Transfer into Erythroid Cells. In: Berns, K.I., Giraud, C. (eds) Adeno-Associated Virus (AAV) Vectors in Gene Therapy. Current Topics in Microbiology and Immunology, vol 218. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80207-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-80207-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80209-6
Online ISBN: 978-3-642-80207-2
eBook Packages: Springer Book Archive